Dental implant surgery in patients in treatment by dabigatran.

Gerardo Gómez-MorenoEsther Fernández-CejasAntonio Aguilar-SalvatierraFélix de CarlosRafael Arcesio Delgado-RuizJosé Luis Calvo-Guirado

Published in: Clinical oral implants research (2016)

Dental implant surgery in patients taking dabigatran can be performed safely providing 12 h have passed since the last dose and local hemostatic measures are applied. Normal dosage can be resumed 8 h after implant surgery.

Keyphrases

minimally invasive
end stage renal disease
newly diagnosed
coronary artery bypass
prognostic factors
atrial fibrillation
patient reported outcomes
oral health